Zueger, Thomas; Kirchner, Paul; Herren, Coline; Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel; Stettler, Christoph (2012). Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. Journal of clinical endocrinology and metabolism, 97(10), E1938-42. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2012-2432
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Zueger JClinEndocrinolMetab 2012.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (136kB) |
Current treatment guidelines generally suggest using lower and weight-adjusted glucocorticoid replacement doses in patients with insufficiency of the hypothalamic-pituitary-adrenal (HPA) axis. Although data in patients with acromegaly revealed a positive association between glucocorticoid dose and mortality, no comparable results exist in patients with nonfunctioning pituitary adenomas (NFPA).
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
UniBE Contributor: |
Fischli, Stefan, Zwahlen, Marcel, Christ, Emanuel, Stettler, Christoph |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0021-972X |
Publisher: |
Endocrine Society |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:26 |
Last Modified: |
05 Dec 2022 14:07 |
Publisher DOI: |
10.1210/jc.2012-2432 |
PubMed ID: |
22872686 |
Web of Science ID: |
000309664400014 |
BORIS DOI: |
10.7892/boris.9375 |
URI: |
https://boris.unibe.ch/id/eprint/9375 (FactScience: 215105) |
Actions (login required)
 |
Edit item |